These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28749824)

  • 1. The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care.
    Bengtson AM; Pence BW; Mollan KR; Edwards JK; Moore RD; OʼCleirigh C; Eaton EF; Eron JJ; Kitahata MM; Mathews WC; Crane H; Mugavero MJ
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):402-408. PubMed ID: 28749824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.
    Chang JL; Tsai AC; Musinguzi N; Haberer JE; Boum Y; Muzoora C; Bwana M; Martin JN; Hunt PW; Bangsberg DR; Siedner MJ
    Ann Intern Med; 2018 Aug; 169(3):146-155. PubMed ID: 29946683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data.
    Nkhoma ET; Coumbis J; Farr AM; Johnston SS; Chu BC; Rosenblatt LC; Seekins D; Villasis-Keever A
    Medicine (Baltimore); 2016 Jan; 95(3):e2480. PubMed ID: 26817882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.
    Mollan KR; Smurzynski M; Eron JJ; Daar ES; Campbell TB; Sax PE; Gulick RM; Na L; O'Keefe L; Robertson KR; Tierney C
    Ann Intern Med; 2014 Jul; 161(1):1-10. PubMed ID: 24979445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transportability From Randomized Trials to Clinical Care: On Initial HIV Treatment With Efavirenz and Suicidal Thoughts or Behaviors.
    Mollan KR; Pence BW; Xu S; Edwards JK; Mathews WC; O'Cleirigh C; Crane HM; Eaton EF; Collier AC; Weideman AMK; Westreich D; Cole SR; Tierney C; Bengtson AM;
    Am J Epidemiol; 2021 Oct; 190(10):2075-2084. PubMed ID: 33972995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
    Arenas-Pinto A; Grund B; Sharma S; Martinez E; Cummins N; Fox J; Klingman KL; Sedlacek D; Collins S; Flynn PM; Chasanov WM; Kedem E; Katlama C; Sierra-Madero J; Afonso C; Brouwers P; Cooper DA;
    Clin Infect Dis; 2018 Jul; 67(3):420-429. PubMed ID: 29538636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies.
    Chang JL; Lee SA; Tsai AC; Musinguzi N; Muzoora C; Bwana B; Boum Y; Haberer JE; Hunt PW; Martin J; Bangsberg DR; Kroetz DL; Siedner MJ
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):982-992. PubMed ID: 29973058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.
    Bengtson AM; Pence BW; Eaton EF; Edwards JK; Eron JJ; Mathews WC; Mollan K; Moore RD; O'Cleirigh C; Geng E; Mugavero MJ
    Antivir Ther; 2018; 23(4):363-372. PubMed ID: 29424697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.
    Bock P; Fatti G; Grimwood A
    Int Health; 2013 Jun; 5(2):132-8. PubMed ID: 24030113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
    Mollan KR; Tierney C; Hellwege JN; Eron JJ; Hudgens MG; Gulick RM; Haubrich R; Sax PE; Campbell TB; Daar ES; Robertson KR; Ventura D; Ma Q; Edwards DRV; Haas DW;
    J Infect Dis; 2017 Sep; 216(5):554-564. PubMed ID: 28931220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial.
    Kintu K; Malaba TR; Nakibuka J; Papamichael C; Colbers A; Byrne K; Seden K; Hodel EM; Chen T; Twimukye A; Byamugisha J; Reynolds H; Watson V; Burger D; Wang D; Waitt C; Taegtmeyer M; Orrell C; Lamorde M; Myer L; Khoo S;
    Lancet HIV; 2020 May; 7(5):e332-e339. PubMed ID: 32386721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens.
    Casado JL; Marín A; Romero V; Bañón S; Moreno A; Perez-Elías MJ; Moreno S; Rodriguez-Sagrado MA
    HIV Med; 2016 Jan; 17(1):46-55. PubMed ID: 26149493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.
    Caro-Vega Y; Schultze A; W Efsen AM; Post FA; Panteleev A; Skrahin A; Miro JM; Girardi E; Podlekareva DN; Lundgren JD; Sierra-Madero J; Toibaro J; Andrade-Villanueva J; Tetradov S; Fehr J; Caylà J; Losso MH; Miller RF; Mocroft A; Kirk O; Crabtree-Ramírez B
    BMC Infect Dis; 2018 Apr; 18(1):191. PubMed ID: 29685113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidal ideation, psychopathology and associated factors among HIV-infected adults in Indonesia.
    Ophinni Y; Adrian ; Siste K; Wiwie M; Anindyajati G; Hanafi E; Damayanti R; Hayashi Y
    BMC Psychiatry; 2020 May; 20(1):255. PubMed ID: 32448151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
    Nachega JB; Hislop M; Dowdy DW; Gallant JE; Chaisson RE; Regensberg L; Maartens G
    AIDS; 2008 Oct; 22(16):2117-25. PubMed ID: 18832875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.
    Domingo P; Suárez-Lozano I; Torres F; Teira R; Lopez-Aldeguer J; Vidal F; Muñoz A; Viciana P; Lozano F; Vergara A; Roca B; García Alcalde ML; Cosín J; Terrón A; Galindo MJ; Geijo P; Ribera E; Gonzalez J; Sanchez T; Lacalle JR; Garrido M
    J Antimicrob Chemother; 2008 Jun; 61(6):1348-58. PubMed ID: 18356150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a systematic review and meta-analysis.
    Jiang HY; Zhang MN; Chen HJ; Yang Y; Deng M; Ruan B
    Int J Infect Dis; 2014 Aug; 25():130-5. PubMed ID: 24911886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.
    Boulle A; Van Cutsem G; Cohen K; Hilderbrand K; Mathee S; Abrahams M; Goemaere E; Coetzee D; Maartens G
    JAMA; 2008 Aug; 300(5):530-9. PubMed ID: 18677025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.
    Gutiérrez F; García L; Padilla S; Alvarez D; Moreno S; Navarro G; Gómez-Sirvent J; Vidal F; Asensi V; Masiá M;
    HIV Med; 2014 Apr; 15(4):213-23. PubMed ID: 24215356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.